KVUE Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio21.44Forward 15.87
EPS (TTM)$0.8446.9% YoY
Profit margin10.6%CONSUMER DEFENSIVE
Market cap$34.58BLarge cap
Wall Street coverage
$19.50median target· current $18.84 (+3.5%)14 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 15.87
- PEG ratio
- 1.51
- P/B
- 3.26
- P/S (TTM)
- 2.26
- EV/EBITDA
- 13.20
Profitability & growth
- ROE (TTM)
- 15.7%
- Operating margin
- 21.6%
- Revenue growth YoY
- 4.5%
- Dividend yield
- 4.5%
- Beta
- 0.50
Last earnings
May 7, 2026 · Estimate $0.26 · Reported $0.32
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
47 articles · sorted by datePage 1 of 3 · 47 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Kenvue Inc.
Company profileKenvue Inc. is a consumer health company globally.
Classification
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 1 KENVUE WAY, SUMMIT, NJ
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$34.58B
Shares outstanding$1.92B
52W high$21.85
52W low$13.53
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent